У нас вы можете посмотреть бесплатно Kristin Anderson, PhD discusses translating insights in the lab into meaningful patient therapeutics или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:
Если кнопки скачивания не
загрузились
НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу
страницы.
Спасибо за использование сервиса ClipSaver.ru
What I love about my research is that it's at the intersection of basic science discovery and clinically impactful research. So what I do is called translational research. That means the ultimate goal is to translate our insights in the lab into therapeutics that are meaningful and translational be relevant for patients. My name is Kristen Anderson and I'm an assistant professor in the Microbiology, Immunology and Cancer Biology Department, and I'm jointly appointed in obstetrics and gynecology. My research is focused on modifying immune cells, specifically T cells, to recognize and kill cancer more effectively. Solid tumors like ovarian and pancreatic cancer present additional obstacles that we need to overcome for this therapy to work. So what my group does is we identify those obstacles and then we come up with creative engineering approaches to overcome them and translate that into a therapeutic for the clinic. The goal is to bring the tools we build in the lab into the clinic for patients. The Manning Institute for Biotechnology is going to support this kind of research extensively. It's going to provide us with access to new technologies and state of the art equipment colleagues and collaborators with diverse expertise. So we can do interdisciplinary studies. And biotechnology and pharmaceutical colleagues who can help us rapidly translate our tools into the clinic. Ultimately, we're going to be surrounded by colleagues with the same shared goal bringing immunotherapies to UVA patients as well as all around the globe.